Johnson Investment Counsel’s Organon & Co OGN Stock Holding History

Johnson Investment Counsel’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,475	Closed	-$251K	–	727
2023 Q3	$251K	Buy	14,475 +231	+2%	+$4.82K	﹤0.01%	590
2023 Q2	$296K	Sell	14,244 -115	-0.8%	-$2.5K	﹤0.01%	562
2023 Q1	$338K	Sell	14,359 -694	-5%	-$18.6K	﹤0.01%	528
2022 Q4	$420K	Sell	15,053 -726	-5%	-$18.6K	0.01%	492
2022 Q3	$369K	Sell	15,779 -205	-1%	-$6.19K	0.01%	494
2022 Q2	$539K	Sell	15,984 -387	-2%	-$13.6K	0.01%	434
2022 Q1	$572K	Sell	16,371 -305	-2%	-$10.4K	0.01%	442
2021 Q4	$508K	Buy	16,676 +10,028	+151%	+$327K	0.01%	466
2021 Q3	$218K	Sell	6,648 -1,863	-22%	-$59.6K	﹤0.01%	608
2021 Q2	$258K	Buy	+8,511	New	+$280K	﹤0.01%	562

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Johnson Investment Counsel's OGN Position: Q4 2023 in Review

Johnson Investment Counsel sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 14,475 shares — an estimated $251K sold.

Johnson Investment Counsel first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $572K in Q1 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Johnson Investment Counsel reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Johnson Investment Counsel sold 14,475 Organon & Co shares in Q4 2023, an estimated $251K.
Johnson Investment Counsel first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
Johnson Investment Counsel's Organon & Co position peaked at $572K in Q1 2022.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Johnson Investment Counsel's 13F filing for Q4 2023, filed 7 Feb 2024.